These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


222 related items for PubMed ID: 2941698

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Toxicity of longterm low dose D-penicillamine therapy in rheumatoid arthritis. Cooperative Systematic Studies of Rheumatic Disease Group.
    J Rheumatol; 1987 Feb; 14(1):67-73. PubMed ID: 2952797
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Blood cytopenias induced by D-penicillamine in rheumatoid arthritis - a report of 51 patients (author's transl)].
    Aymard JP, Netter P, Witz F, Colomb JN, Lederlin P, Pourel J, Gaucher A, Herbeuval R.
    Therapie; 1981 Feb; 36(3):337-41. PubMed ID: 7292413
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Early recognition of adverse effects, especially of kidney lesions, in patients with progressive chronic polyarthritis under D-Penicillamine therapy].
    Otto W, Pietruschka WD, Beenken O.
    Z Gesamte Inn Med; 1975 Aug 01; 30(15):507-9. PubMed ID: 1189496
    [Abstract] [Full Text] [Related]

  • 11. [Chlorbutin, azathioprine, D-penicillamine, and levamisole (Decaris) in the treatment of rheumatoid arthritis patients. I. Comparative analysis of side effects].
    Krel' AA, Kanevskaia MZ, Rashchupkina ZP, Bolotin EV, Chichasova NV.
    Ter Arkh; 1981 Aug 01; 53(7):86-96. PubMed ID: 6457409
    [No Abstract] [Full Text] [Related]

  • 12. [D-penicillamine in rheumatoid arthritis : hematological incidents and accidents (author's transl)].
    Franck JL, Bouteiller G, Gayrard M, Arlet J.
    Sem Hop; 1981 Aug 01; 55(27-30):1325-7. PubMed ID: 228408
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Clinical and prognostic significance of antinuclear factors during D-penicillamine treatment (author's transl)].
    Helmke K, Velcovsky HG, Federlin K.
    Dtsch Med Wochenschr; 1975 Oct 24; 100(43):2198-203. PubMed ID: 1080704
    [Abstract] [Full Text] [Related]

  • 16. Stimulation single fiber EMG study in patients receiving a long-term D-penicillamine treatment for rheumatoid arthritis.
    Dominkus M, Grisold W, Albrecht G.
    Muscle Nerve; 1992 Nov 24; 15(11):1300-1. PubMed ID: 1488070
    [No Abstract] [Full Text] [Related]

  • 17. [D-penicillamine in the treatment of rheumatoid arthritis].
    Gerloni V, Colombo B, Carraière G.
    Reumatismo; 1977 Nov 24; 29(2-3):157-62. PubMed ID: 616962
    [No Abstract] [Full Text] [Related]

  • 18. [Penicillamine: its use in rheumatoid arthritis].
    Colombo B, Gerloni V.
    Recenti Prog Med; 1979 Feb 24; 66(2):136-87. PubMed ID: 155862
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Gold vs D-penicillamine double blind study and followup.
    Thomas MH, Rothermich NO, Philips VK, Bergen W, Hedrick SW.
    J Rheumatol; 1984 Dec 24; 11(6):764-7. PubMed ID: 6240537
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.